Panelists highlight that menin inhibitors represent a breakthrough in the treatment of KMT2A-rearranged AML by targeting the disease’s core epigenetic drivers, with early clinical trials like ...

Acute myeloid leukemia (AML) is a cancer that occurs in your blood and bone marrow. AML specifically affects the white blood cells (WBCs) of your body, causing them to form abnormally. In acute ...

Panelists explain that KMT2A-rearranged acute myeloid leukemia (AML) is a biologically aggressive and diagnostically complex leukemia subtype—especially prevalent in pediatric and therapy-related ...

Advancements in cancer treatments and doctors’ understanding of acute myeloid leukemia (AML) mean that more and more people survive the condition each year. • The 5-year overall survival rate ...

The European Commission has approved Astellas’ Xospata (gilteritinib) for patients with relapsed or refractory FLT3-positive acute myeloid leukemia (AML), cementing its lead over a rival drug ...

Genomic DNA was isolated from bone marrow and/or peripheral blood samples of leukemia patients and sent to the DCAL (Frankfurt/Main, Germany). Patient samples were obtained from different study ...

In this Primer, Bradshaw et al. review the epidemiology, pathophysiology, diagnosis and management of bacterial vaginosis, discuss its effects on quality of life and highlight areas for research.

This marks a major milestone in the development of IHL-42X, confirming the completion of clinical data collection and enabling final statistical analysis to begin. The Company is on track to deliver ...